← Back to Clinical Trials
Recruiting NCT06640907

NCT06640907 Feasibility Study and Pilot Hybrid Effectiveness-Implementation Trial for the Universal Prevention of Maternal Perinatal Mental Disorders as Normalized Routine Practice (e-Perinatal Pilot)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06640907
Status Recruiting
Phase
Sponsor University of Seville
Condition Perinatal Depression
Study Type INTERVENTIONAL
Enrollment 96 participants
Start Date 2025-05-02
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
e-Perinatal personalized mHealth intervention integrated into routine maternal careStandard routine maternal care with general perinatal health information

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 96 participants in total. It began in 2025-05-02 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is part of the e-Perinatal project, funded by the European Research Council. This research project will follow the first three phases recommended by the Medical Research Council (MRC) framework for the development and evaluation of complex interventions (Skivington et al., 2021). The primary aim is to evaluate the feasibility and acceptability of implementing an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. Using a pilot, two-arm, cluster-randomized hybrid type 1 clinical trial, the study will assess key implementation outcomes and preliminary effectiveness indicators. The findings will inform the design of a future large clinical trial, intending to evaluate the effectiveness, cost-effectiveness, and implementation of the intervention as part of maternal care.

Eligibility Criteria

Inclusion criteria for mothers: * Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers * Must be pregnant for at least 16 weeks or have given birth within the last 5 months at the time of enrollment * Must be at least 18 years old * Must have access to a mobile phone and internet connection * Must be able to read, write, and understand Spanish * Must have a personal email account Inclusion criteria for partners (or significant others): * Must receive an invitation to participate from a woman already enrolled in the study * Must be at least 18 years old * Must have access to a mobile phone and internet connection * Must be able to read, write, and understand Spanish * Must have a personal email account Exclusion criteria for mothers: * Meet diagnostic criteria for anxiety or depression, as determined by a structured clinical interview * Be on a waiting list or currently receiving psychological or pharmacological treatment for any mental health or substance use condition Exclusion criteria for partners (or significant others): * There are no exclusion criteria for partners

Contact & Investigator

Central Contact

Francisco J. Nieto-Casado, PhD in Psychology

✉ eperinatal@us.es

📞 684785391

Frequently Asked Questions

Who can join the NCT06640907 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Perinatal Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06640907 currently recruiting?

Yes, NCT06640907 is actively recruiting participants. Contact the research team at eperinatal@us.es for enrollment information.

Where is the NCT06640907 trial being conducted?

This trial is being conducted at Mairena del Aljarafe, Spain.

Who is sponsoring the NCT06640907 clinical trial?

NCT06640907 is sponsored by University of Seville. The trial plans to enroll 96 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology